By admin 
The research delves into a critical area of public health, especially as cannabis use becomes increasingly normalized and accessible across many parts of the United States. Stress is frequently cited as one of the primary motivations for individuals turning to cannabis, often seeking its purported temporary relief from anxiety and daily pressures. Paradoxically, the very act of frequent use, while offering fleeting solace, might inadvertently be interfering with the body’s intrinsic mechanisms designed to manage stress effectively over the long term. This creates a potential feedback loop where the substance used to alleviate stress could, over time, contribute to a dysregulated stress system, potentially perpetuating the cycle of use.
At the helm of this significant investigation was Anita Cservenka, an associate professor in the OSU College of Liberal Arts and a distinguished expert in neurocognitive aspects of substance use. Her team’s work is notable for being among a relatively small number of studies that rigorously explore the relationship between frequent cannabis use and the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis stands as the major neuroendocrine system, a sophisticated communication network between the brain and endocrine glands, responsible for orchestrating the body’s physiological response to stress. When activated, the HPA axis releases hormones, including cortisol, to help the body adapt and cope with perceived threats or challenges. A disruption in this axis can have wide-ranging implications for physical and mental health.
The urgency and relevance of these findings are underscored by the dramatic rise in cannabis use, particularly among young adults in the United States. Recent epidemiological data highlights a significant shift in consumption patterns: approximately 29% of adults aged 19 to 30 reported using cannabis within the previous 30 days. This rate represents a near doubling over the past 15 years, illustrating a profound change in societal attitudes and behaviors towards the substance. Even more striking is the statistic revealing that over 10% of individuals within this demographic report using cannabis at least 20 times within a 30-day period, indicating frequent, almost daily, engagement. This percentage has more than doubled in the last decade and a half, signaling a growing segment of the population engaging in what could be considered regular or heavy use. This escalating prevalence makes understanding the potential biological consequences, such as changes in stress hormone levels, critically important for public health initiatives and clinical guidance.
It is crucial to interpret these findings with scientific precision, as Cservenka herself cautions. The study establishes a correlation between frequent cannabis use and elevated morning cortisol levels, but it does not, at this stage, definitively prove a cause-and-effect relationship. In other words, the research does not conclude that frequent cannabis use causes higher cortisol levels upon waking, nor does it suggest that elevated morning cortisol causes individuals to use cannabis more frequently. Establishing causality would necessitate a more rigorous, longitudinal research design, where the same groups of individuals are observed and measured over extended periods, allowing researchers to track changes and determine the temporal sequence of events. "We would need to study the same groups of people over a longer period of time to understand any cause-and-effect relationship, but we think this provides an important starting point," Cservenka emphasized, highlighting the foundational nature of their current findings.
Understanding "Why Cortisol Matters" is central to appreciating the implications of this research. Cortisol, often dubbed the "stress hormone," is a glucocorticoid hormone synthesized and released by the adrenal glands, small endocrine glands located atop the kidneys. Hormones, acting as chemical messengers, orchestrate a myriad of vital processes throughout the body. While primarily known for its role in the "fight or flight" response, cortisol’s functions extend far beyond stress management. It is indispensable for maintaining homeostasis, playing essential roles in fighting infection and modulating immune responses, maintaining stable blood pressure, regulating blood sugar levels (by increasing glucose in the bloodstream for energy), and influencing metabolism of fats, proteins, and carbohydrates.
In the short term, the acute release of cortisol is a beneficial and adaptive response, equipping the body to cope with immediate stressors by mobilizing energy resources and sharpening focus. However, when cortisol levels remain chronically elevated for prolonged periods, the physiological benefits diminish, giving way to a cascade of negative health consequences. Persistent high cortisol has been consistently linked to an increased risk of various adverse health outcomes, including heightened anxiety, clinical depression, impaired cognitive function, weight gain (particularly abdominal fat), weakened immune function, and a greater susceptibility to cardiovascular diseases such as hypertension and heart attack. It can also contribute to metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes. Therefore, any factor that consistently alters the body’s normal cortisol rhythm warrants significant scientific scrutiny.
To investigate these physiological shifts, Cservenka and her OSU colleagues, Julia Donner and Alexia Obrochta, focused their efforts on what is scientifically known as the Cortisol Awakening Response, or CAR. CAR is a well-established and robust physiological phenomenon: it represents a rapid, transient increase in cortisol levels that all healthy individuals experience shortly after waking, typically peaking around 30 minutes post-awakening. "CAR is the cortisol rise that all people experience in the morning, peaking around 30 minutes after they wake up," Cservenka explained. This morning surge is not a response to an immediate stressor but rather an anticipatory mechanism, a proactive preparation of the body to meet the metabolic and psychological demands of the upcoming day. It is thought to be crucial for cognitive performance, alertness, and general well-being throughout the day.
The measurement of CAR typically involves collecting saliva samples, which are non-invasive and accurately reflect circulating cortisol levels, at two critical time points: immediately upon waking (often within 5-10 minutes) and then again precisely 30 minutes later. The difference between the second measurement and the first provides a quantitative indicator of the magnitude of this morning cortisol increase. This resulting difference is considered a proxy for how effectively the body prepares itself to handle the routine demands and potential stressors of the day ahead.
Intriguingly, the OSU researchers found that the size of this morning cortisol increase – the actual CAR response – was similar between frequent cannabis users and non-users. This suggests that the dynamic rise in cortisol after waking was not significantly altered. However, the critical and novel difference identified in this study appeared at the starting point. Individuals who frequently used cannabis already had significantly more cortisol circulating in their bodies at the moment they woke up, before the CAR even began. This indicates a higher baseline level of the stress hormone from the outset of their day, a finding that points to a potential chronic elevation or dysregulation rather than an altered acute response.
This discovery holds profound implications, suggesting a "Potential Biological Signal of Problematic Cannabis Use." Cservenka elaborated, "Our research suggests cortisol levels upon awakening may serve as a neurobiological marker of problematic cannabis use, and that connection needs to be investigated further." This idea opens doors for potential early detection or objective assessment tools in clinical settings. However, she also pointed out a divergence from earlier studies: "Earlier studies by other researchers found CAR to be blunted in frequent cannabis users, but we didn’t replicate that finding, which suggests there is a lot of nuance that could be related to analytic strategies and sample characteristics."
This discrepancy between the OSU findings (elevated baseline cortisol) and previous research (blunted CAR) underscores the inherent complexity of studying the relationship between cannabis use and the body’s intricate stress system. Several factors could account for these differences. Methodological variations, such as the timing and number of saliva samples collected, the definition of "frequent use," and the specific analytical strategies employed to calculate CAR, can all influence results. Furthermore, sample characteristics play a crucial role. Differences in study populations, including age, gender, frequency and duration of cannabis use, the specific types or strains of cannabis consumed (e.g., THC vs. CBD content), routes of administration, co-occurring mental health conditions (like anxiety or depression, which themselves impact the HPA axis), and even genetic predispositions, could all contribute to varied outcomes across studies. The evolving landscape of cannabis products and their potency further complicates comparisons.
Despite these nuances, Cservenka asserts that it is entirely reasonable to consider the possibility that frequent cannabis users may experience disruptions in their normal daily stress rhythms. Such chronic alterations in the HPA axis, evidenced by higher baseline cortisol, could potentially contribute to a detrimental feedback cycle. In this hypothesized cycle, a poorly regulated stress system, perhaps struggling to return to baseline or constantly operating at a higher alert level, might itself encourage further cannabis use as individuals seek relief from perceived or physiological stress. This could lead to a self-perpetuating pattern of dependence and further HPA axis dysregulation, creating a challenging loop for individuals to break free from.
The broader context of cannabis legalization and increasing accessibility further emphasizes the need for comprehensive research like this. While cannabis is increasingly seen as benign or even therapeutic, understanding its long-term physiological impacts is paramount. The current study, by highlighting a potential alteration in a fundamental stress biomarker, contributes significantly to this understanding. Future research will undoubtedly focus on longitudinal studies to establish causality, investigate the impact of different cannabis constituents and usage patterns, and explore whether these cortisol changes predict other health outcomes or problematic use patterns. Such investigations are crucial for developing evidence-based public health recommendations, clinical guidelines, and personalized intervention strategies for individuals who use cannabis frequently.
The research conducted by Oregon State University, and supported by the OSU Center for the Humanities and the OSU College of Liberal Arts, serves as a vital step in unraveling the intricate web of connections between cannabis use and human physiology, particularly the delicate balance of our stress response system. As cannabis continues to integrate into society, a deep, scientific understanding of its full spectrum of effects, both therapeutic and potentially disruptive, remains an indispensable endeavor.
